NeuroprotectivePreclinical Evidence

PE-22-28

Also known as: Spadin derivative, TREK-1 antagonist

Synthetic nootropic peptide that enhances cognition through TREK-1 potassium channel inhibition.

Benefits

6

Conditions

5

Evidence

Preclinical animal models of depression and cognition+ studies

Source

Synthetic TREK-1 channel antagonist

Overview

Synthetic nootropic peptide that enhances cognition through TREK-1 potassium channel inhibition.

Mechanism of Action

Potently blocks TREK-1 potassium channels (~100-fold more than spadin), increases neuronal excitability and synaptic transmission, upregulates BDNF expression, promotes hippocampal neurogenesis within 4 days, enhances serotonergic transmission.

Key Benefits

  • Rapid cognitive enhancement
  • Improves memory and learning
  • Reduces depression and anxiety
  • Promotes neurogenesis
  • Enhances executive function
  • Fast-acting (effects within days)

Clinical Applications

Depression (treatment-resistant)Cognitive impairmentMemory deficitsStress-related disordersPost-stroke cognitive dysfunction

Dosing Guidelines

Subcutaneous injection

Typical Dose0.5-1 mg
FrequencyOnce daily
DurationResearch protocols typically 4-30 days

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Preclinical
Studies

Preclinical animal models of depression and cognition

Summary

Strong preclinical evidence for rapid antidepressant and cognitive effects. No human clinical trials. Faster onset than traditional antidepressants in animal models.

Safety Information

Potential Side Effects

  • Unknown in humans
  • Potential overstimulation

Contraindications

  • Pregnancy
  • Breastfeeding
  • Seizure disorders

Interactions

  • Unknown - no human data

Quick Facts

CategoryNeuroprotective
SourceSynthetic TREK-1 channel antagonist
Legal StatusResearch compound, not approved for human use
Gabriel Brain Score
87/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.